INDUSTRY × Observational × Arthritis, Rheumatoid × Clear all UP-RISING
Recruiting
678 enrolled
Comprehensive Segmental Revision System
Active not recruiting
105 enrolled
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
Completed
140,706 enrolled
DANBIO
Completed
38,396 enrolled
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Completed
2,207 enrolled 10 charts
HRP
Terminated
4 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.
Completed
7,807 enrolled 73 charts
A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents
Completed
1,132 enrolled
Impact of Anti-citrullinated Protein Antibody Status on Treatment Response and Treatment Persistence in Participants With Rheumatoid Arthritis (RA) Who Are Treated With Abatacept or Tumor Necrosis Factor Inhibitors in Australia
Completed
2,052 enrolled
NexT
Completed
1,723 enrolled
PASSRRA
Completed
22 enrolled
A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.
Completed
200 enrolled
Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy
Completed
110 enrolled 19 charts
An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis
Completed
135 enrolled 21 charts
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent
Completed
505 enrolled 15 charts
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)
Completed
9 enrolled 17 charts
FasT
Completed
1,117 enrolled 10 charts
A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea
Completed
1,700 enrolled
DALI
Completed
705 enrolled 15 charts